Why the study?
It was unknown whether using antidepressants with strong serotonin reuptake inhibition is associated with a decreased incidence of ischemic stroke and myocardial infarction.
Does the use of antidepressants with strong inhibition of serotonin reuptake reduce the incidence of ischemic stroke and myocardial infarction compared to weak inhibitors in adult new users of SSRIs or third-generation antidepressants?
Does the use of antidepressants with strong inhibition of serotonin reuptake reduce the incidence of ischemic stroke and myocardial infarction compared to weak inhibitors in adult new users of SSRIs or third-generation antidepressants?
Answers are grounded in this paper and cite their sources.
Antidepressants with strong serotonin reuptake inhibition may be associated with a small decrease in the rate of ischemic stroke compared to weak inhibitors, with no difference in myocardial infarction risk.
OBJECTIVE: To assess whether use of antidepressants with strong inhibition of serotonin reuptake is associated with a decreased incidence of ischemic stroke and myocardial infarction (MI). METHODS: We conducted a cohort study using the UK Clinical Practice Research Datalink and considering new users of selective serotonin reuptake inhibitors (SSRIs) or third-generation antidepressants who were ≥18 years of age between 1995 and 2014. Using a nested case-control approach, we matched each case of a first ischemic stroke or MI identified during follow-up with up to 30 controls on age, sex, calendar time, and duration of follow-up. We estimated incidence rate ratios (RRs) and 95% confidence intervals (CIs) of each outcome associated with current use of strong compared with weak inhibitors of serotonin reuptake using conditional logistic regression. RESULTS: The cohort included 938,388 incident users of SSRIs (n = 868,755) or third-generation antidepressants (n = 69,633). Mean age at cohort entry was 46 years (64% women). During follow-up, 15,860 cases of ischemic stroke and 8,626 cases of MI were identified and matched to 473,712 and 258,022 controls, respectively. Compared with current use of weak inhibitors of serotonin reuptake, current use of strong inhibitors was associated with a decreased rate of ischemic stroke (RR 0.88, 95% CI 0.80-0.97), but the effect size was smaller in some sensitivity analyses. The rate of MI was similar between strong and weak inhibitors (RR 1.00, 95% CI 0.87-1.15). CONCLUSION: Our large population-based study suggests that antidepressants strongly inhibiting serotonin reuptake may be associated with a small decrease in the rate of ischemic stroke.
No takes yet. Share an insight, caveat, or question.
Douros et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: